Evidence map›Paper›PMID 18313027›Full record

ArticleAmerican journal of human genetics2008

Human RFT1 deficiency leads to a disorder of N-linked glycosylation.

Micha A Haeuptle, François M Pujol, Christine Neupert, Bryan Winchester, Alexander J Kastaniotis, Markus Aebi, Thierry Hennet

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genetic defects in dolichol metabolism.Journal of inherited metabolic disease · 2015
    Review
  14. Article
  15. Review
  16. Review
  17. Protein secretion and the endoplasmic reticulum.Cold Spring Harbor perspectives in biology · 2012
    Review
  18. Congenital protein hypoglycosylation diseases.The application of clinical genetics · 2012
    Article
  19. Congenital disorders of glycosylation (CDG): it's (nearly) all in it!Journal of inherited metabolic disease · 2011
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Micha A HaeuptleInstitute of Physiology and Zürich Center for Integrative Human Physiology, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.
François M Pujol
Christine Neupert
Bryan Winchester
Alexander J Kastaniotis
Markus Aebi
Thierry Hennet
École Polytechnique Fédérale de Lausanne · CHUniversity of Oulu · FIUniversity of Zurich · CHUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

N-linked glycosylation is an essential posttranslational modification of proteins in eukaryotes. The substrate of N-linked glycosylation, dolichol pyrophosphate (DolPP)-GlcNAc(2)Man(9)Glc(3), is assembled through a complex series of ordered reactions requiring the translocation of the intermediate DolPP-GlcNAc(2)Man(5) structure across the endoplasmic-reticulum membrane. A young patient diagnosed with a congenital disorder of glycosylation characterized by an intracellular accumulation of DolPP-GlcNAc(2)Man(5) was found to carry a homozygous point mutation in the RFT1 gene. The c.199C-->T mutation introduced the amino acid substitution p.R67C. The human RFT1 protein shares 22% identity with its yeast ortholog, which is involved in the translocation of DolPP-GlcNAc(2)Man(5) from the cytosolic into the lumenal side of the endoplasmic reticulum. Despite the low sequence similarity between the yeast and the human RFT1 proteins, we demonstrated both their functional orthology and the pathologic effect of the human p.R67C mutation by complementation assay in Deltarft1 yeast cells. The causality of the RFT1 p.R67C mutation was further established by restoration of normal glycosylation profiles in patient-derived fibroblasts after lentiviral expression of a normal RFT1 cDNA. The definition of the RFT1 defect establishes the functional conservation of the DolPP-GlcNAc(2)Man(5) translocation process in eukaryotes. RFT1 deficiency in both yeast and human cells leads to the accumulation of incomplete DolPP-GlcNAc(2)Man(5) and to a profound glycosylation disorder in humans.

Indexed as

AdolescentAmino Acid SequenceDNA Mutational AnalysisFemaleGenetic Complementation TestGlycosylationHumansMembrane GlycoproteinsMetabolic DiseasesMolecular Sequence DataPedigreePoint MutationPolyisoprenyl Phosphate SugarsProtein Processing, Post-TranslationalSaccharomyces cerevisiaeGlc(3)Man(9)(GlcNAc)(2)-diphosphate-dolicholMembrane GlycoproteinsPolyisoprenyl Phosphate SugarsRFT1 protein, human

Identifiers

PMID18313027
PMCPMC2427296
OpenAlexW2081944144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.